Register

Login

+
  • View all news
  • Vets news
  • Vet Nursing news
  • Business news
  • + More
    • Videos
    • Podcasts
  • View all clinical
  • Small animal
  • Livestock
  • Equine
  • Exotics
  • Vet Times jobs home
  • All Jobs
  • Your ideal job
  • Post a job
  • Career Advice
  • Students
About
Contact Us
For Advertisers
NewsClinicalJobs

Vets

All Vets newsSmall animalLivestockEquineExoticWork and well-beingOpinion

Vet Nursing

All Vet Nursing newsSmall animalLivestockEquineExoticWork and well-beingOpinion

Business

All Business newsHuman resourcesBig 6SustainabilityFinanceDigitalPractice profilesPractice developments

+ More

VideosPodcasts

The latest veterinary news, delivered straight to your inbox.

Choose which topics you want to hear about and how often.

About

Advertise with us

Recruitment

Contact us

Vets

All Vets news

Small animal

Livestock

Equine

Exotic

Work and well-being

Opinion

Vet Nursing

All Vet Nursing news

Small animal

Livestock

Equine

Exotic

Work and well-being

Opinion

Business

All Business news

Human resources

Big 6

Sustainability

Finance

Digital

Practice profiles

Practice developments

Clinical

All Clinical content

Small animal

Livestock

Equine

Exotics

Jobs

All Jobs content

All Jobs

Your ideal job

Post a job

Career Advice

Students

More

All More content

Videos

Podcasts


Terms and conditions

Complaints policy

Cookie policy

Privacy policy

© Veterinary Business Development Ltd 2025

IPSO_regulated

4 Apr 2016

Liver fluke: latest guidance on treatment in cattle and sheep

Ian Nanjiani focuses on available treatment options, with guidance on how to get the best out of them by targeting the correct life cycle stages at the right time of year.

author_img

Ian Nanjiani

Job Title



Liver fluke: latest guidance on treatment in cattle and sheep

Figure 1. Liver fluke life cycle. (from COWS Technical Manual For Veterinarians and Advisors: Liver Fluke, 2013).

Fasciola hepatica requires an intermediate host (the mud-snail Galba truncatula) to complete the ruminant infection cycle (Figure 1)1. The snails have fairly specific requirements, needing water, warmth and nutrients provided by algae they consume in slow moving water, so are commonly found at the edges of standing bodies of water, streams, or land poached by machinery or livestock.

Figure 1. Liver fluke life cycle. (from COWS Technical Manual For Veterinarians and Advisors: Liver Fluke, 2013).
Figure 1. Liver fluke life cycle. (from COWS Technical Manual For Veterinarians and Advisors: Liver Fluke, 2013).

Temperature and moisture affect the multiplication of both the snail and the parasite’s infectious stages (the newly hatched miracidia, which infect the snail, and the metacercariae on the herbage, which infect or reinfect the host).

Temperatures of 10°C or above allow snail and parasite multiplication, and the capacity of a snail to produce approximately 100,000 offspring in a three to four-month period2 – coupled with a 500-fold parasite multiplication within the snail3 – can lead to substantial pasture metacercarial loads in relatively short periods of time. This is particularly the case in warmer, wet weather when both the snail and the parasite multiply much more rapidly.

Following ingestion by the host (in our case, the grazing ruminant, although other wildlife – including man – are susceptible to infection), the metacercariae hatch and immature fluke migrate through the gut wall to the liver. The immature fluke take 10 to 12 weeks to reach the bile ducts, where they lay their eggs, so the life cycle is completed in around 17 to 19 weeks. Adults survive in sheep for a number of years, although adult loads in cattle may reduce with time as the bile duct solidifies, preventing blood feeding.

Historically, the May to October period has provided the necessary temperature and moisture characteristics for fluke multiplication, although milder winters lately have extended this period – increasing the period of infection risk, allowing better pasture survival on infective stages and increasing the likelihood of early snail and animal infection in subsequent seasons. Current global warming predictions point to an increasing risk period and an expansion of suitable snail habitats, and warm, wet summers represent the highest risk periods for acute infection.

Acute disease occurs following parenchymal damage caused by mass migration of immature stages and can be rapidly fatal in sheep (primarily through blood loss). Acute disease is rare in cattle, though – perhaps due to their larger, tougher liver. The syndrome is generally preceded by a warm, wet spell encouraging high pasture metacercarial loads, and treatment of acute infection must therefore target the immature parasite stages.

Subacute and chronic disease is common in both sheep and cattle later in the grazing season and into the housing season, with animals classically showing loss of condition, submandibular oedema (bottle-jaw), anaemia and a predisposition to some clostridial diseases. Additionally, degrees of immunosuppression (sufficient to interfere with the tuberculin test) have been reported by some authors, with implications for statutory TB testing. Subclinical infection has been implicated in reduced production in terms of growth, fertility and milk production.

Economic impact

Fasciolosis is an “iceberg” disease – visible losses are only part of the full impact, and animals don’t appear to develop protective immunity following infection. Lower fluke burdens may still affect growth rates, carcase composition, fertility and, in dairy cattle, reduced milk yields and changes in milk quality without any external signs of disease. Annual losses to the industry attributable to fasciolosis (liver condemnation and lost production in England) have been estimated to be £13 million to £15 million (beef and sheep) and £23 million (cattle)4.

against Fasciola hepatica. Adapted from COWS 2013, SCOPS 2013 and NOAH/VMD joint statement 2013.
Table 1. Summary of different actives licensed for use in cattle and sheep against Fasciola hepatica. Adapted from COWS 2013, SCOPS 2013 and NOAH/VMD joint statement 2013.

In England in 2012, more than 16% of cattle livers (259,000) and nearly 7% of sheep livers (582,000) were excluded from the human food chain due to liver fluke infestation5, similar to levels described by other authors6. This highlight the importance of robust investigation of ill-thrift on farms, and the value of postmortem data, either from disease investigations, or from abattoir feedback.

Treatment

The same general principles of good practice apply to flukicides as all medicines for food-producing animals, and are summarised below.

General fluke treatment principles

  • Accurate dosing is key
  • – weigh [or weighband] animals individually to dose accurately
  • – check/calibrate dosing equipment before use)
  • •  overdosing will increase drug residue depletion time, and may result in toxicity for animals with poor hepatic function
  • •  underdosing leaves parasites alive, and increases the risk of resistance development
  • Select product based on parasitic life cycle stage targeted (Table 1) and treatment objectives (Table 2):
  • •  treatment of acute disease needs products active against the immature stages causing disease
  • •  strategic treatments to reduce pasture contamination should target adults (to reduce egg output)
  • Flukicides have no persistent effect (unlike many anthelmintics), so repeated treatments are often necessary
  • •  for example, use of an adulticide will leave immature stages untreated, so a repeat treatment after 6 to 12 weeks (depending on product used) to allow the immature stages to become susceptible and die before they commence egg laying may be necessary in high infection areas using a strategic treatment approach
  • •  animals will be at risk of reinfection if they remain on infested pastures
  • Check product withholding periods
  • •  particularly important for milk-producing animals
  • – adopting strategic control at dry-off may be best option in risk farms/groups
  • Only use combination anthelmintic/flukicides when specifically indicated
  • • ensure the flukicide/anthelmintic is targeting the appropriate parasite stages
  • Any suspected treatment failure should be reported to the market authorisation holder, and thoroughly investigated
  • • consider testing efficacy on-farm using faecal egg count reduction test (FECRT)
  • –  composite FECRT tests have been validated for use in sheep (2 composites of samples from 10 animals, pre and post-treatment, three weeks apart)7,8.
  • – a useful “directional” tool for efficacy.

Flukicide resistance

Table 2. Treatment scenarios.
Table 2. Treatment scenarios.

Triclabendazole (TBZ) resistance has been reported in the UK6,11-13, so its use should ideally be reserved for the treatment of acute disease in sheep (and rarely cattle). The faecal egg count reduction test has been used to detect TBZ resistance and appears to function well enough for field use in the absence of validated in vitro methods, provided sufficient animals are tested7,8.

Albendazole resistance has been reported in Spain and Sweden6, but not (yet) in the UK, and Closantel treatment failure was recently reported in Sweden14. We have seen from nematode anthelmintics over-reliance on “the bottle” can increase the selection pressure for drug-resistant parasites.

Treatment scenarios

Applying these general treatment principles to each farm requires a detailed understanding of its stocking and grazing patterns, and control of liver fluke disease should be an important part of a farm health plan drawn up with the farmer’s veterinary surgeon, as discussed in this publication (Nanjiani, 201515).

Monitoring the levels of infection in sheep and cattle using fluke egg counts, bulk milk antibody, abattoir returns and veterinary investigation of ill-thrifty animals is essential to successful control, as is assessing the fluke risk of the pastures – using as accurate a fluke risk forecast as is available. NADIS provides roughly correct regional forecasts based on rainfall and temperature, which can be translated into farm/pasture risk in discussion with the farmer.

Recent research from the EU-funded GLOWORM project has developed mathematical models that attempt to accurately predict increased metacercarial abundance/infection risk, so more accurate prediction systems will hopefully appear in the near future16.

A variety of treatment scenarios and therapeutic options exist (Tables 1 and 2), which are either intervention treatments (to safeguard health and welfare) or strategic (group) treatments to minimise pasture contamination.

Production benefits have been demonstrated treating infected animals before overt clinical signs develop17, which is logical given the damage F hepatica causes the liver.

The basic fluke treatment approach in endemic farms comprises:

  • treatment soon after housing (to reduce/eliminate burden acquired in the grazing season)
  • a pre-turnout/early season treatment to reduce egg shedding of adults and, therefore, pasture build-up
  • a mid-season adulticide treatment to reduce pasture shedding (this treatment is risk based and may not be required in low challenge situations)
  • FECs and fluke forecasts will assist decision-making
  • therapeutic treatment in the first grazing season is only generally required in high challenge situations
  • in particularly high challenge situations, multiple treatments may be required

Given the warm, wet winter of 2015/2016, we can expect an increased risk of fluke this year:

  • cattle and sheep are both susceptible to F hepatica infection, so bear this in mind when assessing pasture risk
  • product choice and timing will be informed by treatment objectives, class of animal, clinical picture, time of year, recent weather patterns/fluke forecast, stage of fluke being targeted, farm risk and disease history (from clinical investigations, monitoring including FEC, bulk tank monitoring, blood tests, slaughterhouse feedback)
  • defining treatment schedules remains as much “art” as science

Conclusion

As for so many parasites, the treatment of F hepatica is not a straightforward affair, with the parasite expanding its footprint and probably its risk period in the UK. Our product armoury is limited (particularly so for dairy cattle) – products have no persistent effect, resistance is reported, and livestock will generally show signs of clinical disease only when substantial liver damage has occurred.

The complex epidemiology means no “one-size-fits-all” treatment regimen can be applied to all farms. This article has focused on treatment, but it is integrated parasite control using a combination of risk-based grazing, close monitoring of stock (maximising all data sources including bulk milk, FECs, abattoir feedback) and strategic product use informed by climatic fluke prediction models that provides our best bet for on-farm control.

It’s time to sit with our clients and develop integrated control plans for all major parasites – we can’t just keep hitting the bottle.